EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Value attributes of advanced therapy medicinal products: a documentary analysis of comments received from stakeholders during reimbursement decisions to England’s National Institute of Health and Care Excellence

Nermina Ferizovic iD, Ruth Plackett, Caroline S Clarke, Rachael Hunter, Nick Freemantle

Expert Review of Pharmacoeconomics & Outcomes Research · 2025

DOI: 10.1080/14737167.2025.2455405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, 2025. Verfasst von Nermina Ferizovic und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Department of Primary Care and Population Health, University College London, London, UK. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical, Reimbursement Mechanisms, Delivery of Health Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Advanced therapy medicinal products (ATMPs) are transformative healthcare interventions, however, there has been limited research exploring their value. The objective of this study was to conduct a thematic analysis as part of a documentary analysis to identify value attributes of ATMPs. METHODS: As part of the NICE assessment processes in England, stakeholders are invited to provide comments on the technology. Nineteen NICE technology assessments (TAs) related to ATMPs were identified and subsequently included in a thematic analysis. All codes (and themes) were generated inductively from the text to reduce bias. RESULTS: This study found that the attributes of value of ATMPs can be categorized into three themes: treatment factors, innovation factors, and wider factors. That is, attributes of value of these interventions include not only direct treatment factors, although this was the largest category, but also additional factors such as those related to innovation and wider impacts the intervention may have, beyond the patient receiving therapy. CONCLUSIONS: This thematic analysis of stakeholder comments submitted to NICE as part of TAs for ATMPs enhances the understanding of attributes of value of ATMPs. The findings are applicable to a wider geography.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Technology Assessment, BiomedicalReimbursement MechanismsDelivery of Health CareHumansEnglandDecision MakingStakeholder Participation

Stichwörter der Autor:innen

Advanced therapy medicinal producthealth technology assessmenttechnology appraisalthematic analysisvalue

Autor:innen und Institutionen

  • Research Department of Primary Care and Population Health, University College London, London, UK.
  • Comprehensive Clinical Trials Unit, University College London, London, UK.

ORCID-Profile: Nermina Ferizovic

Zitieren

APA

Ferizovic, N., Plackett, R., Clarke, C. S., Hunter, R., & Freemantle, N. (2025). Value attributes of advanced therapy medicinal products: a documentary analysis of comments received from stakeholders during reimbursement decisions to England’s National Institute of Health and Care Excellence. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2025.2455405

Vancouver

Ferizovic N, Plackett R, Clarke CS, Hunter R, Freemantle N. Value attributes of advanced therapy medicinal products: a documentary analysis of comments received from stakeholders during reimbursement decisions to England’s National Institute of Health and Care Excellence. Expert Review of Pharmacoeconomics & Outcomes Research. 2025. doi:10.1080/14737167.2025.2455405

BibTeX
@article{Ferizovic2025,
  author = {Ferizovic, Nermina and Plackett, Ruth and Clarke, Caroline S and Hunter, Rachael and Freemantle, Nick},
  title = {Value attributes of advanced therapy medicinal products: a documentary analysis of comments received from stakeholders during reimbursement decisions to England’s National Institute of Health and Care Excellence},
  journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
  year = {2025},
  doi = {10.1080/14737167.2025.2455405}
}
Kostenlos starten →